134 related articles for article (PubMed ID: 1575063)
21. A study of the changes in the level of serum IgG4 antibody and soluble CD23 (s-CD23) in nasal allergy patients with immunotherapy.
Ito H; Nishimura J; Mamiya S; Suzuki M; Yokota A; Baba S
Auris Nasus Larynx; 1993; 20(3):185-96. PubMed ID: 8297266
[TBL] [Abstract][Full Text] [Related]
22. Allergy to house dust mites and asthma.
Milián E; Díaz AM
P R Health Sci J; 2004 Mar; 23(1):47-57. PubMed ID: 15125219
[TBL] [Abstract][Full Text] [Related]
23. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.
Baron-Bodo V; Batard T; Nguyen H; Fréreux M; Horiot S; Harwanegg C; Bergmann KC; de Beaumont O; Moingeon P
Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348
[TBL] [Abstract][Full Text] [Related]
24. Distribution of IgE and IgG antibody levels against house dust mites in schoolchildren, and their relation with asthma.
Shibasaki M; Noguchi E; Takeda K; Takita H
J Asthma; 1997; 34(3):235-42. PubMed ID: 9168851
[TBL] [Abstract][Full Text] [Related]
25. A comparison between IgE and IgG4 as markers of allergy in children: an experimental trial in a model of natural antigen avoidance.
Piacentini GL; Guerresi S; Kantar A; Lubrano L; Olivieri F; Boner AL; Peroni DG
Int J Immunopathol Pharmacol; 2011; 24(4):1049-56. PubMed ID: 22230410
[TBL] [Abstract][Full Text] [Related]
26. [IgE, IgG1 and IgG4 antibodies against bodily and fecal extracts of Dermatophagoides farinae].
Yasumatsu Y
Arerugi; 1993 Jun; 42(6):728-37. PubMed ID: 8347091
[TBL] [Abstract][Full Text] [Related]
27. [Nasal smear cytology in bronchial asthma: correlation of appearance and numbers of nasal smear mast cells, eosinophils or basophils and serum IgE antibodies to house dust mite in patients with bronchial asthma].
Hirano K; Shimojo N; Saito K; Hoshioka A; Katsuki T; Homma K; Kohno Y; Niimi H
Arerugi; 1995 Sep; 44(9):1117-24. PubMed ID: 8534207
[TBL] [Abstract][Full Text] [Related]
28. IgE and IgG anti-house dust mite specificities in allergic disease.
Hales BJ; Martin AC; Pearce LJ; Laing IA; Hayden CM; Goldblatt J; Le Souëf PN; Thomas WR
J Allergy Clin Immunol; 2006 Aug; 118(2):361-7. PubMed ID: 16890759
[TBL] [Abstract][Full Text] [Related]
29. Local production of total IgE and specific antibodies to the house dust mite in adenoid tissue.
Shin SY; Choi SJ; Hur GY; Lee KH; Kim SW; Cho JS; Park HS
Pediatr Allergy Immunol; 2009 Mar; 20(2):134-41. PubMed ID: 18657051
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of immune parameters (including specific IgG4) during immunotherapy.
Ruiz de León Loriga J; Lluch Pérez M; Valero Santiago A; Zamorano Calderón M; Huguet Casals J; Malet Casajuana A; García Calderón PA
Allergol Immunopathol (Madr); 1989; 17(3):119-27. PubMed ID: 2479244
[TBL] [Abstract][Full Text] [Related]
31. Antigen Der f I from the dust mite Dermatophagoides farinae: structural comparison with Der p I from Dermatophagoides pteronyssinus and epitope specificity of murine IgG and human IgE antibodies.
Heymann PW; Chapman MD; Platts-Mills TA
J Immunol; 1986 Nov; 137(9):2841-7. PubMed ID: 2428875
[TBL] [Abstract][Full Text] [Related]
32. Solid-phase enzyme immunoassay for anti-mite IgE and IgG antibodies in allergic patients.
Kobayashi N; Terada E; Haida M; Ito M; Miyamoto T; Okudaira H
Ann Allergy; 1988 Aug; 61(2):97-9. PubMed ID: 3041879
[TBL] [Abstract][Full Text] [Related]
33. House dust mite and cockroach exposure are strong risk factors for positive allergy skin test responses in the Childhood Asthma Management Program.
Huss K; Adkinson NF; Eggleston PA; Dawson C; Van Natta ML; Hamilton RG
J Allergy Clin Immunol; 2001 Jan; 107(1):48-54. PubMed ID: 11149990
[TBL] [Abstract][Full Text] [Related]
34. Humoral response to subcutaneous, oral, and nasal immunotherapy for allergic rhinitis due to Dermatophagoides pteronyssinus.
Piazza I; Bizzaro N
Ann Allergy; 1993 Nov; 71(5):461-9. PubMed ID: 7755664
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Der p1-specific antibody levels in children with allergic airway disease and healthy controls.
Aydogan M; Mete N; Yazi D; Akkoc T; Ozdemir C; Blaser K; Akdis M; Akdis C; Bahceciler N; Barlan I
Pediatr Allergy Immunol; 2007 Jun; 18(4):320-5. PubMed ID: 17584311
[TBL] [Abstract][Full Text] [Related]
36. Cross-antigenicity between the scabies mite, Sarcoptes scabiei, and the house dust mite, Dermatophagoides pteronyssinus.
Arlian LG; Vyszenski-Moher DL; Ahmed SG; Estes SA
J Invest Dermatol; 1991 Mar; 96(3):349-54. PubMed ID: 1705952
[TBL] [Abstract][Full Text] [Related]
37. [Inhibitory activity of mite IgG4, antibody on antigen-induced histamine release from human peripheral blood leukocytes].
Yamakoshi T
Nihon Jibiinkoka Gakkai Kaiho; 1992 Jul; 95(7):996-1004. PubMed ID: 1380985
[TBL] [Abstract][Full Text] [Related]
38. Indoor mite allergen levels, specific IgE prevalence and IgE cross-inhibition pattern among asthmatic children in Haikou, southern China.
Zheng YW; Chen S; Lai XX; Gjesing B; Zhong NS; Spangfort MD
Chin Med J (Engl); 2012 Sep; 125(17):3059-63. PubMed ID: 22932181
[TBL] [Abstract][Full Text] [Related]
39. Purification and characterization of a 94 KD high molecular weight allergen from house dust mite, Dermatophagoides pteronyssinus.
Wey JJ; Lee HF; Chang TH; Chou CC; Hsieh KH; Huang JH
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 Nov; 30(4):228-41. PubMed ID: 10592827
[TBL] [Abstract][Full Text] [Related]
40. Seasonal variation of IgG subclass antibodies to house dust mite in sera from mite-sensitive asthmatic patients.
Nahm DH; Park HS; Kim CW; Park JW; Hong CS
Ann Allergy Asthma Immunol; 1998 May; 80(5):411-5. PubMed ID: 9609612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
